Venture Partners VII L. P. Sofinnova serves as Executive at Trius Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Venture Partners VII L. P. Sofinnova has executed 8 insider transactions totaling $19.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 22, 2014 involved selling 323,932 shares valued at $5.2M.
Venture Partners VII L. P. Sofinnova currently holds 2,766,657 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Partners VII L. P. Sofinnova has been a net seller of TSRX stock. They have purchased $9.4M and sold $9.8M worth of shares.
Venture Partners VII L. P. Sofinnova's most recent insider trade was on May 22, 2014, when they sold 323,932 shares at $16.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 24, 2012 | DRTX | $5.3M | Purchase | 588,236 | $9.00 | Discretionary |
| Mar 10, 2011 | AMRN | $4.4M | Sale | 606,300 | $7.26 | Discretionary |
| Mar 9, 2011 | AMRN | $222.6K | Sale | 30,700 | $7.25 | Discretionary |
| Aug 6, 2010 | TSRX | $4.2M | Purchase | 830,000 | $5.00 | Discretionary |
| Aug 6, 2010 | TSRX | $3.9M | Conversion | 893,395 | $4.38 | Discretionary |
| Aug 6, 2010 | TSRX | $0 | Conversion | 1,892,177 | $N/A | Discretionary |